Chembio Diagnostics (CEMI) Peer Comparison

$0.46

$0.00 (0.22%)

As on 27-Apr-2023 16:00EDT

Market cap

$17 Mln

Revenue (TTM)

$48 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Edit

	Chembio Diagnostics (CEMI)	Provention Bio (PRVB)
Market cap ($ Mln)	17	2,375
Revenue ($ Mln)	48	13
Net Profit ($ Mln)	-23.29	-113.57
Net Margin (%)	-51.56	-818.77
RoE (%)	-89.47	133.43
Price to Earnings	--	--
Price-To-Book	0.66	5.31

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Chembio Diagnostics (CEMI)	Provention Bio (PRVB)
Operating Revenue	48.34	12.90
Cost of Revenue	38.58	0.51
Gross Profit	9.76	12.38
Operating Expenses	30.16	140.54
Operating Profit (EBIT)	-20.40	-128.16
Other Income	--	--
Profit before Tax	-23.26	-126.96
Provision for Tax	0.03	-13.39
Profit after Tax (Net Income)	-23.29	-113.57
Minority Interest	--	--
Consolidated Profit	--	--

Liabilities ($ Mln)

	Chembio Diagnostics (CEMI)	Provention Bio (PRVB)
Shareholder's Funds	17.80	121.85
Minority Interest	--	--
Non-Current Liabilities	5.51	24.62
Current Liabilities	39.30	90.39
Total Liabilities	62.61	236.86

Assets ($ Mln)

	Chembio Diagnostics (CEMI)	Provention Bio (PRVB)
Non-Current Assets	14.16	62.21
Current Assets	48.45	174.65
Total Assets	62.61	236.86
Total Debt*	25.08	23.91
Net Current Assets	9.15	84.26

Cashflow ($ Mln)

	Chembio Diagnostics (CEMI)	Provention Bio (PRVB)
Cash From Operating Activities	-12.69	-75.41
Cash Flow from Investing Activities	--	--
Cash from Financing Activities	3.37	129.38
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Chembio Diagnostics (CEMI)	Provention Bio (PRVB)
ROCE (%)	-45.22	155.86
ROE (%)	-89.47	133.43
ROA (%)	-34.29	-60.98
EBIT Margin (%)	--	--
Net Margin (%)	-48.18	-880.69
Cash Profit Margin (%)	--	--

Growth Ratios

	Chembio Diagnostics (CEMI)	Provention Bio (PRVB)
Revenue Growth (%)	0.31	8.24
EBIT Growth (%)	--	--
Net Profit Growth (%)	31.30	0.76
EPS Growth (%)	0.48	0.17
Book Value Growth (%)	--	--

Valuation Ratios

	Chembio Diagnostics (CEMI)	Provention Bio (PRVB)
Price / Earnings	-0.30	-6.98
Price / Book Value	0.40	6.51
Dividend Yield (%)	--	--
EV/EBITDA	-0.95	-5.23
Market Cap ($ Cr)	--	--

Solvency Ratios

	Chembio Diagnostics (CEMI)	Provention Bio (PRVB)
Debt to Equity	1.41	0.20
Short term debt to equity ratio	1.10	--
Current Ratio	1.23	1.93
Quick Ratio	1.04	1.92
Interest Coverage	-53.41	-123.59

Operating Efficiency Ratios

	Chembio Diagnostics (CEMI)	Provention Bio (PRVB)
Debtors to sales (%)	38.73	10.54
Asset Turnover	0.71	0.07
Receivable days	113.96	38.49
Inventory Days	97.69	878.17
Payable days	52.49	3,676.40
Cash Conversion Cycle	159.15	-2,759.74

Annual
Quarterly